Global Insomnia Medication Market Growth 2023-2029

February 2023 | 117 pages | ID: GB6A94A6CC31EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Insomnia Medication Industry Forecast” looks at past sales and reviews total world Insomnia Medication sales in 2022, providing a comprehensive analysis by region and market sector of projected Insomnia Medication sales for 2023 through 2029. With Insomnia Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insomnia Medication industry.

This Insight Report provides a comprehensive analysis of the global Insomnia Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Insomnia Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Insomnia Medication market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insomnia Medication and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insomnia Medication.

The global Insomnia Medication market size is projected to grow from US$ 2858.1 million in 2022 to US$ 3645.5 million in 2029; it is expected to grow at a CAGR of 3645.5 from 2023 to 2029.

United States market for Insomnia Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Insomnia Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Insomnia Medication is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Insomnia Medication players cover Eisai, Merck, Pfizer, Sanofi, Takeda, Vanda Pharmaceuticals, Astellas, Dainippon Sumitomo and ECR Pharmaceuticals (Valeant), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Insomnia Medication market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Nonbenzodiazepine Receptor Agonists
• Benzodiazepine Receptor Agonists
• The Selective Melatonin Receptor Agonist Ramelteon
• Sedating Antidepressants

Segmentation by application

• Adults
• Kids

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Eisai
• Merck
• Pfizer
• Sanofi
• Takeda
• Vanda Pharmaceuticals
• Astellas
• Dainippon Sumitomo
• ECR Pharmaceuticals (Valeant)
• Flynn Pharma
• Johnson & Johnson
• Meda
• Somnus Therapeutics
• Purdue Pharma
• Neurim
• Minerva Neurosciences
• Pernix Therapeutics
• SkyePharma
• Paratek Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Insomnia Medication market?

What factors are driving Insomnia Medication market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Insomnia Medication market opportunities vary by end market size?

How does Insomnia Medication break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Insomnia Medication Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Insomnia Medication by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Insomnia Medication by Country/Region, 2018, 2022 & 2029
2.2 Insomnia Medication Segment by Type
  2.2.1 Nonbenzodiazepine Receptor Agonists
  2.2.2 Benzodiazepine Receptor Agonists
  2.2.3 The Selective Melatonin Receptor Agonist Ramelteon
  2.2.4 Sedating Antidepressants
2.3 Insomnia Medication Sales by Type
  2.3.1 Global Insomnia Medication Sales Market Share by Type (2018-2023)
  2.3.2 Global Insomnia Medication Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Insomnia Medication Sale Price by Type (2018-2023)
2.4 Insomnia Medication Segment by Application
  2.4.1 Adults
  2.4.2 Kids
2.5 Insomnia Medication Sales by Application
  2.5.1 Global Insomnia Medication Sale Market Share by Application (2018-2023)
  2.5.2 Global Insomnia Medication Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Insomnia Medication Sale Price by Application (2018-2023)

3 GLOBAL INSOMNIA MEDICATION BY COMPANY

3.1 Global Insomnia Medication Breakdown Data by Company
  3.1.1 Global Insomnia Medication Annual Sales by Company (2018-2023)
  3.1.2 Global Insomnia Medication Sales Market Share by Company (2018-2023)
3.2 Global Insomnia Medication Annual Revenue by Company (2018-2023)
  3.2.1 Global Insomnia Medication Revenue by Company (2018-2023)
  3.2.2 Global Insomnia Medication Revenue Market Share by Company (2018-2023)
3.3 Global Insomnia Medication Sale Price by Company
3.4 Key Manufacturers Insomnia Medication Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Insomnia Medication Product Location Distribution
  3.4.2 Players Insomnia Medication Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR INSOMNIA MEDICATION BY GEOGRAPHIC REGION

4.1 World Historic Insomnia Medication Market Size by Geographic Region (2018-2023)
  4.1.1 Global Insomnia Medication Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Insomnia Medication Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Insomnia Medication Market Size by Country/Region (2018-2023)
  4.2.1 Global Insomnia Medication Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Insomnia Medication Annual Revenue by Country/Region (2018-2023)
4.3 Americas Insomnia Medication Sales Growth
4.4 APAC Insomnia Medication Sales Growth
4.5 Europe Insomnia Medication Sales Growth
4.6 Middle East & Africa Insomnia Medication Sales Growth

5 AMERICAS

5.1 Americas Insomnia Medication Sales by Country
  5.1.1 Americas Insomnia Medication Sales by Country (2018-2023)
  5.1.2 Americas Insomnia Medication Revenue by Country (2018-2023)
5.2 Americas Insomnia Medication Sales by Type
5.3 Americas Insomnia Medication Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Insomnia Medication Sales by Region
  6.1.1 APAC Insomnia Medication Sales by Region (2018-2023)
  6.1.2 APAC Insomnia Medication Revenue by Region (2018-2023)
6.2 APAC Insomnia Medication Sales by Type
6.3 APAC Insomnia Medication Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Insomnia Medication by Country
  7.1.1 Europe Insomnia Medication Sales by Country (2018-2023)
  7.1.2 Europe Insomnia Medication Revenue by Country (2018-2023)
7.2 Europe Insomnia Medication Sales by Type
7.3 Europe Insomnia Medication Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Insomnia Medication by Country
  8.1.1 Middle East & Africa Insomnia Medication Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Insomnia Medication Revenue by Country (2018-2023)
8.2 Middle East & Africa Insomnia Medication Sales by Type
8.3 Middle East & Africa Insomnia Medication Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Insomnia Medication
10.3 Manufacturing Process Analysis of Insomnia Medication
10.4 Industry Chain Structure of Insomnia Medication

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Insomnia Medication Distributors
11.3 Insomnia Medication Customer

12 WORLD FORECAST REVIEW FOR INSOMNIA MEDICATION BY GEOGRAPHIC REGION

12.1 Global Insomnia Medication Market Size Forecast by Region
  12.1.1 Global Insomnia Medication Forecast by Region (2024-2029)
  12.1.2 Global Insomnia Medication Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Insomnia Medication Forecast by Type
12.7 Global Insomnia Medication Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Eisai
  13.1.1 Eisai Company Information
  13.1.2 Eisai Insomnia Medication Product Portfolios and Specifications
  13.1.3 Eisai Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Eisai Main Business Overview
  13.1.5 Eisai Latest Developments
13.2 Merck
  13.2.1 Merck Company Information
  13.2.2 Merck Insomnia Medication Product Portfolios and Specifications
  13.2.3 Merck Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Merck Main Business Overview
  13.2.5 Merck Latest Developments
13.3 Pfizer
  13.3.1 Pfizer Company Information
  13.3.2 Pfizer Insomnia Medication Product Portfolios and Specifications
  13.3.3 Pfizer Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Pfizer Main Business Overview
  13.3.5 Pfizer Latest Developments
13.4 Sanofi
  13.4.1 Sanofi Company Information
  13.4.2 Sanofi Insomnia Medication Product Portfolios and Specifications
  13.4.3 Sanofi Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Sanofi Main Business Overview
  13.4.5 Sanofi Latest Developments
13.5 Takeda
  13.5.1 Takeda Company Information
  13.5.2 Takeda Insomnia Medication Product Portfolios and Specifications
  13.5.3 Takeda Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Takeda Main Business Overview
  13.5.5 Takeda Latest Developments
13.6 Vanda Pharmaceuticals
  13.6.1 Vanda Pharmaceuticals Company Information
  13.6.2 Vanda Pharmaceuticals Insomnia Medication Product Portfolios and Specifications
  13.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Vanda Pharmaceuticals Main Business Overview
  13.6.5 Vanda Pharmaceuticals Latest Developments
13.7 Astellas
  13.7.1 Astellas Company Information
  13.7.2 Astellas Insomnia Medication Product Portfolios and Specifications
  13.7.3 Astellas Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Astellas Main Business Overview
  13.7.5 Astellas Latest Developments
13.8 Dainippon Sumitomo
  13.8.1 Dainippon Sumitomo Company Information
  13.8.2 Dainippon Sumitomo Insomnia Medication Product Portfolios and Specifications
  13.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Dainippon Sumitomo Main Business Overview
  13.8.5 Dainippon Sumitomo Latest Developments
13.9 ECR Pharmaceuticals (Valeant)
  13.9.1 ECR Pharmaceuticals (Valeant) Company Information
  13.9.2 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Portfolios and Specifications
  13.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 ECR Pharmaceuticals (Valeant) Main Business Overview
  13.9.5 ECR Pharmaceuticals (Valeant) Latest Developments
13.10 Flynn Pharma
  13.10.1 Flynn Pharma Company Information
  13.10.2 Flynn Pharma Insomnia Medication Product Portfolios and Specifications
  13.10.3 Flynn Pharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Flynn Pharma Main Business Overview
  13.10.5 Flynn Pharma Latest Developments
13.11 Johnson & Johnson
  13.11.1 Johnson & Johnson Company Information
  13.11.2 Johnson & Johnson Insomnia Medication Product Portfolios and Specifications
  13.11.3 Johnson & Johnson Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Johnson & Johnson Main Business Overview
  13.11.5 Johnson & Johnson Latest Developments
13.12 Meda
  13.12.1 Meda Company Information
  13.12.2 Meda Insomnia Medication Product Portfolios and Specifications
  13.12.3 Meda Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Meda Main Business Overview
  13.12.5 Meda Latest Developments
13.13 Somnus Therapeutics
  13.13.1 Somnus Therapeutics Company Information
  13.13.2 Somnus Therapeutics Insomnia Medication Product Portfolios and Specifications
  13.13.3 Somnus Therapeutics Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Somnus Therapeutics Main Business Overview
  13.13.5 Somnus Therapeutics Latest Developments
13.14 Purdue Pharma
  13.14.1 Purdue Pharma Company Information
  13.14.2 Purdue Pharma Insomnia Medication Product Portfolios and Specifications
  13.14.3 Purdue Pharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Purdue Pharma Main Business Overview
  13.14.5 Purdue Pharma Latest Developments
13.15 Neurim
  13.15.1 Neurim Company Information
  13.15.2 Neurim Insomnia Medication Product Portfolios and Specifications
  13.15.3 Neurim Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 Neurim Main Business Overview
  13.15.5 Neurim Latest Developments
13.16 Minerva Neurosciences
  13.16.1 Minerva Neurosciences Company Information
  13.16.2 Minerva Neurosciences Insomnia Medication Product Portfolios and Specifications
  13.16.3 Minerva Neurosciences Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Minerva Neurosciences Main Business Overview
  13.16.5 Minerva Neurosciences Latest Developments
13.17 Pernix Therapeutics
  13.17.1 Pernix Therapeutics Company Information
  13.17.2 Pernix Therapeutics Insomnia Medication Product Portfolios and Specifications
  13.17.3 Pernix Therapeutics Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.17.4 Pernix Therapeutics Main Business Overview
  13.17.5 Pernix Therapeutics Latest Developments
13.18 SkyePharma
  13.18.1 SkyePharma Company Information
  13.18.2 SkyePharma Insomnia Medication Product Portfolios and Specifications
  13.18.3 SkyePharma Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.18.4 SkyePharma Main Business Overview
  13.18.5 SkyePharma Latest Developments
13.19 Paratek Pharmaceuticals
  13.19.1 Paratek Pharmaceuticals Company Information
  13.19.2 Paratek Pharmaceuticals Insomnia Medication Product Portfolios and Specifications
  13.19.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.19.4 Paratek Pharmaceuticals Main Business Overview
  13.19.5 Paratek Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Insomnia Medication Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Insomnia Medication Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Nonbenzodiazepine Receptor Agonists
Table 4. Major Players of Benzodiazepine Receptor Agonists
Table 5. Major Players of The Selective Melatonin Receptor Agonist Ramelteon
Table 6. Major Players of Sedating Antidepressants
Table 7. Global Insomnia Medication Sales by Type (2018-2023) & (K Pcs)
Table 8. Global Insomnia Medication Sales Market Share by Type (2018-2023)
Table 9. Global Insomnia Medication Revenue by Type (2018-2023) & ($ million)
Table 10. Global Insomnia Medication Revenue Market Share by Type (2018-2023)
Table 11. Global Insomnia Medication Sale Price by Type (2018-2023) & (USD/Pcs)
Table 12. Global Insomnia Medication Sales by Application (2018-2023) & (K Pcs)
Table 13. Global Insomnia Medication Sales Market Share by Application (2018-2023)
Table 14. Global Insomnia Medication Revenue by Application (2018-2023)
Table 15. Global Insomnia Medication Revenue Market Share by Application (2018-2023)
Table 16. Global Insomnia Medication Sale Price by Application (2018-2023) & (USD/Pcs)
Table 17. Global Insomnia Medication Sales by Company (2018-2023) & (K Pcs)
Table 18. Global Insomnia Medication Sales Market Share by Company (2018-2023)
Table 19. Global Insomnia Medication Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Insomnia Medication Revenue Market Share by Company (2018-2023)
Table 21. Global Insomnia Medication Sale Price by Company (2018-2023) & (USD/Pcs)
Table 22. Key Manufacturers Insomnia Medication Producing Area Distribution and Sales Area
Table 23. Players Insomnia Medication Products Offered
Table 24. Insomnia Medication Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Insomnia Medication Sales by Geographic Region (2018-2023) & (K Pcs)
Table 28. Global Insomnia Medication Sales Market Share Geographic Region (2018-2023)
Table 29. Global Insomnia Medication Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Insomnia Medication Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Insomnia Medication Sales by Country/Region (2018-2023) & (K Pcs)
Table 32. Global Insomnia Medication Sales Market Share by Country/Region (2018-2023)
Table 33. Global Insomnia Medication Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Insomnia Medication Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Insomnia Medication Sales by Country (2018-2023) & (K Pcs)
Table 36. Americas Insomnia Medication Sales Market Share by Country (2018-2023)
Table 37. Americas Insomnia Medication Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Insomnia Medication Revenue Market Share by Country (2018-2023)
Table 39. Americas Insomnia Medication Sales by Type (2018-2023) & (K Pcs)
Table 40. Americas Insomnia Medication Sales by Application (2018-2023) & (K Pcs)
Table 41. APAC Insomnia Medication Sales by Region (2018-2023) & (K Pcs)
Table 42. APAC Insomnia Medication Sales Market Share by Region (2018-2023)
Table 43. APAC Insomnia Medication Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Insomnia Medication Revenue Market Share by Region (2018-2023)
Table 45. APAC Insomnia Medication Sales by Type (2018-2023) & (K Pcs)
Table 46. APAC Insomnia Medication Sales by Application (2018-2023) & (K Pcs)
Table 47. Europe Insomnia Medication Sales by Country (2018-2023) & (K Pcs)
Table 48. Europe Insomnia Medication Sales Market Share by Country (2018-2023)
Table 49. Europe Insomnia Medication Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Insomnia Medication Revenue Market Share by Country (2018-2023)
Table 51. Europe Insomnia Medication Sales by Type (2018-2023) & (K Pcs)
Table 52. Europe Insomnia Medication Sales by Application (2018-2023) & (K Pcs)
Table 53. Middle East & Africa Insomnia Medication Sales by Country (2018-2023) & (K Pcs)
Table 54. Middle East & Africa Insomnia Medication Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Insomnia Medication Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Insomnia Medication Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Insomnia Medication Sales by Type (2018-2023) & (K Pcs)
Table 58. Middle East & Africa Insomnia Medication Sales by Application (2018-2023) & (K Pcs)
Table 59. Key Market Drivers & Growth Opportunities of Insomnia Medication
Table 60. Key Market Challenges & Risks of Insomnia Medication
Table 61. Key Industry Trends of Insomnia Medication
Table 62. Insomnia Medication Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Insomnia Medication Distributors List
Table 65. Insomnia Medication Customer List
Table 66. Global Insomnia Medication Sales Forecast by Region (2024-2029) & (K Pcs)
Table 67. Global Insomnia Medication Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Insomnia Medication Sales Forecast by Country (2024-2029) & (K Pcs)
Table 69. Americas Insomnia Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Insomnia Medication Sales Forecast by Region (2024-2029) & (K Pcs)
Table 71. APAC Insomnia Medication Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Insomnia Medication Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Europe Insomnia Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Insomnia Medication Sales Forecast by Country (2024-2029) & (K Pcs)
Table 75. Middle East & Africa Insomnia Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Insomnia Medication Sales Forecast by Type (2024-2029) & (K Pcs)
Table 77. Global Insomnia Medication Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Insomnia Medication Sales Forecast by Application (2024-2029) & (K Pcs)
Table 79. Global Insomnia Medication Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Eisai Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 81. Eisai Insomnia Medication Product Portfolios and Specifications
Table 82. Eisai Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. Eisai Main Business
Table 84. Eisai Latest Developments
Table 85. Merck Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck Insomnia Medication Product Portfolios and Specifications
Table 87. Merck Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Pfizer Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Insomnia Medication Product Portfolios and Specifications
Table 92. Pfizer Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. Pfizer Main Business
Table 94. Pfizer Latest Developments
Table 95. Sanofi Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 96. Sanofi Insomnia Medication Product Portfolios and Specifications
Table 97. Sanofi Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. Sanofi Main Business
Table 99. Sanofi Latest Developments
Table 100. Takeda Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 101. Takeda Insomnia Medication Product Portfolios and Specifications
Table 102. Takeda Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. Takeda Main Business
Table 104. Takeda Latest Developments
Table 105. Vanda Pharmaceuticals Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 106. Vanda Pharmaceuticals Insomnia Medication Product Portfolios and Specifications
Table 107. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 108. Vanda Pharmaceuticals Main Business
Table 109. Vanda Pharmaceuticals Latest Developments
Table 110. Astellas Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 111. Astellas Insomnia Medication Product Portfolios and Specifications
Table 112. Astellas Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 113. Astellas Main Business
Table 114. Astellas Latest Developments
Table 115. Dainippon Sumitomo Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 116. Dainippon Sumitomo Insomnia Medication Product Portfolios and Specifications
Table 117. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 118. Dainippon Sumitomo Main Business
Table 119. Dainippon Sumitomo Latest Developments
Table 120. ECR Pharmaceuticals (Valeant) Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 121. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Portfolios and Specifications
Table 122. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 123. ECR Pharmaceuticals (Valeant) Main Business
Table 124. ECR Pharmaceuticals (Valeant) Latest Developments
Table 125. Flynn Pharma Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 126. Flynn Pharma Insomnia Medication Product Portfolios and Specifications
Table 127. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 128. Flynn Pharma Main Business
Table 129. Flynn Pharma Latest Developments
Table 130. Johnson & Johnson Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 131. Johnson & Johnson Insomnia Medication Product Portfolios and Specifications
Table 132. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 133. Johnson & Johnson Main Business
Table 134. Johnson & Johnson Latest Developments
Table 135. Meda Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 136. Meda Insomnia Medication Product Portfolios and Specifications
Table 137. Meda Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 138. Meda Main Business
Table 139. Meda Latest Developments
Table 140. Somnus Therapeutics Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 141. Somnus Therapeutics Insomnia Medication Product Portfolios and Specifications
Table 142. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 143. Somnus Therapeutics Main Business
Table 144. Somnus Therapeutics Latest Developments
Table 145. Purdue Pharma Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 146. Purdue Pharma Insomnia Medication Product Portfolios and Specifications
Table 147. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 148. Purdue Pharma Main Business
Table 149. Purdue Pharma Latest Developments
Table 150. Neurim Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 151. Neurim Insomnia Medication Product Portfolios and Specifications
Table 152. Neurim Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 153. Neurim Main Business
Table 154. Neurim Latest Developments
Table 155. Minerva Neurosciences Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 156. Minerva Neurosciences Insomnia Medication Product Portfolios and Specifications
Table 157. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 158. Minerva Neurosciences Main Business
Table 159. Minerva Neurosciences Latest Developments
Table 160. Pernix Therapeutics Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 161. Pernix Therapeutics Insomnia Medication Product Portfolios and Specifications
Table 162. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 163. Pernix Therapeutics Main Business
Table 164. Pernix Therapeutics Latest Developments
Table 165. SkyePharma Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 166. SkyePharma Insomnia Medication Product Portfolios and Specifications
Table 167. SkyePharma Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 168. SkyePharma Main Business
Table 169. SkyePharma Latest Developments
Table 170. Paratek Pharmaceuticals Basic Information, Insomnia Medication Manufacturing Base, Sales Area and Its Competitors
Table 171. Paratek Pharmaceuticals Insomnia Medication Product Portfolios and Specifications
Table 172. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 173. Paratek Pharmaceuticals Main Business
Table 174. Paratek Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Insomnia Medication
Figure 2. Insomnia Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Insomnia Medication Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Insomnia Medication Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Insomnia Medication Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Nonbenzodiazepine Receptor Agonists
Figure 10. Product Picture of Benzodiazepine Receptor Agonists
Figure 11. Product Picture of The Selective Melatonin Receptor Agonist Ramelteon
Figure 12. Product Picture of Sedating Antidepressants
Figure 13. Global Insomnia Medication Sales Market Share by Type in 2022
Figure 14. Global Insomnia Medication Revenue Market Share by Type (2018-2023)
Figure 15. Insomnia Medication Consumed in Adults
Figure 16. Global Insomnia Medication Market: Adults (2018-2023) & (K Pcs)
Figure 17. Insomnia Medication Consumed in Kids
Figure 18. Global Insomnia Medication Market: Kids (2018-2023) & (K Pcs)
Figure 19. Global Insomnia Medication Sales Market Share by Application (2022)
Figure 20. Global Insomnia Medication Revenue Market Share by Application in 2022
Figure 21. Insomnia Medication Sales Market by Company in 2022 (K Pcs)
Figure 22. Global Insomnia Medication Sales Market Share by Company in 2022
Figure 23. Insomnia Medication Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Insomnia Medication Revenue Market Share by Company in 2022
Figure 25. Global Insomnia Medication Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Insomnia Medication Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Insomnia Medication Sales 2018-2023 (K Pcs)
Figure 28. Americas Insomnia Medication Revenue 2018-2023 ($ Millions)
Figure 29. APAC Insomnia Medication Sales 2018-2023 (K Pcs)
Figure 30. APAC Insomnia Medication Revenue 2018-2023 ($ Millions)
Figure 31. Europe Insomnia Medication Sales 2018-2023 (K Pcs)
Figure 32. Europe Insomnia Medication Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Insomnia Medication Sales 2018-2023 (K Pcs)
Figure 34. Middle East & Africa Insomnia Medication Revenue 2018-2023 ($ Millions)
Figure 35. Americas Insomnia Medication Sales Market Share by Country in 2022
Figure 36. Americas Insomnia Medication Revenue Market Share by Country in 2022
Figure 37. Americas Insomnia Medication Sales Market Share by Type (2018-2023)
Figure 38. Americas Insomnia Medication Sales Market Share by Application (2018-2023)
Figure 39. United States Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Insomnia Medication Sales Market Share by Region in 2022
Figure 44. APAC Insomnia Medication Revenue Market Share by Regions in 2022
Figure 45. APAC Insomnia Medication Sales Market Share by Type (2018-2023)
Figure 46. APAC Insomnia Medication Sales Market Share by Application (2018-2023)
Figure 47. China Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Insomnia Medication Sales Market Share by Country in 2022
Figure 55. Europe Insomnia Medication Revenue Market Share by Country in 2022
Figure 56. Europe Insomnia Medication Sales Market Share by Type (2018-2023)
Figure 57. Europe Insomnia Medication Sales Market Share by Application (2018-2023)
Figure 58. Germany Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Insomnia Medication Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Insomnia Medication Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Insomnia Medication Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Insomnia Medication Sales Market Share by Application (2018-2023)
Figure 67. Egypt Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Insomnia Medication Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Insomnia Medication in 2022
Figure 73. Manufacturing Process Analysis of Insomnia Medication
Figure 74. Industry Chain Structure of Insomnia Medication
Figure 75. Channels of Distribution
Figure 76. Global Insomnia Medication Sales Market Forecast by Region (2024-2029)
Figure 77. Global Insomnia Medication Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Insomnia Medication Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Insomnia Medication Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Insomnia Medication Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Insomnia Medication Revenue Market Share Forecast by Application (2024-2029)